|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TISSUE-SPECIFIC STEM CELLS |
1 The University of Texas Health Science Center at Houston and the Texas Heart Institute, Houston, Texas 77030
* To whom correspondence should be addressed. E-mail: yong-jian.geng{at}uth.tmc.edu.
| Abstract |
|---|
Acting as a reverse transcriptase that maintains nuclear telomere length and replication potential, telomerase usually decreases in expression and activities when mammalian stem cells undergo terminal differentiation. This study identified a subpopulation of mesenchymal stem cells (MSCs) from adult adipose tissue, which co-express telomerase and myocardin A, a key regulator of cardiovascular myogenic development. The telomerase/myocardin A–positive MSCs differentiated into cardiovascular myogenic cells, while retaining expression and activation of the telomerase catalytic unit, TERT, at a level comparable to that of embryonic stem cells (ESCs). Both myocardin A and TERT could be co-immunoprecipitated from the developing MSCs and ESC-derived embryoid bodies (EBs) with either anti-TERT or anti-myocardin A antibodies, suggesting the formation of TERT-myocardin A complexes in the MSCs and EBs. The proteins pulled down with anti-myocardin antibodies showed almost the same levels of telomerase activities as those precipitated with anti-TERT antibodies. Overexpression of myocardin A by cDNA transfection significantly increased telomerase activities and promoted telomere synthesis by MSCs. The data from this study indicate a potentially novel function of myocardin A in maintaining the myogenic stemness in developing MSCs and EBs by enhancing telomerase activation and promoting myogenic gene expression.
Key Words. Stem cell, telomerase, myocardin, heart, development, myogenesis
This article has been cited by other articles:
![]() |
P. E. Westerweel and M. C. Verhaar Directing Myogenic Mesenchymal Stem Cell Differentiation Circ. Res., September 12, 2008; 103(6): 560 - 561. [Full Text] [PDF] |
||||
![]() |
R. W. Grauss, J. van Tuyn, P. Steendijk, E. M. Winter, D. A. Pijnappels, B. Hogers, A. C. Gittenberger-De Groot, R. van der Geest, A. van der Laarse, A. A.F. de Vries, et al. Forced Myocardin Expression Enhances the Therapeutic Effect of Human Mesenchymal Stem Cells After Transplantation in Ischemic Mouse Hearts Stem Cells, April 1, 2008; 26(4): 1083 - 1093. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
